Center for Health Sciences 
University of Wisconsin-Madison 
University Hospital and Clinics 
Director 
Office of Recombinant DNA Activities 
Building 31, Room 3B10 
National Institute of Health 
Bethesda, MD 20205 
Dear Director: 
I have recently had the opportunity to review the Rifkin 
Amendments which I believe reflect a rather naive approach to 
this problem. Such constraints as he proposes would seriously 
impair both ongoing and future research in this area that 
could very well have importance in hoped-for ultimate therapy 
of such genetic disorders as Duchenne muscular dystrophy. 
As a member of the Medical Advisory Board of the Muscular 
Dystrophy Association, I would like to express my objections 
to this unscientific proposal, which, because of its probable 
affect on research and hopefully treatment, poses a very amoral 
600 Highland Avenue 
Madison, Wisconsin 53792 
October 19, 1984 
act . 
Sincerely yours. 
Henry A. Peters, M.D. 
Professor 
DEPARTMENT OF NEUROLOGY 
HAP : d j 
[545] 
